At BioAI, we are developing world-leading machine learning technology to map the causal biology of disease, develop digital biomarkers, and identify novel drug targets, for the development of better medicine.
BioAI’s PredictX Platform intakes your data and generates novel insights. PredictX is capable of ingesting a range of data types including: Digital Pathology, Multiomics, and Real-World Evidence. Using multimodal data and the most advanced AI methodologies, including In-silico phenotype projection and integrated deep learning, we can build predictive and prognostic models across a broad range of therapeutic areas.
Founded by a group of friends who started by scribbling their ideas on a piece of paper, today we offer smart, innovative services to dozens of clients worldwide.
Our team of experts has a proven track record in developing strategic partnerships with the Pharma industry and solving major challenges in R&D
Company Details
- Employees
- 12
- Founded
- -
- Address
- 1662 Elm St, Manchester,new Hampshire 03101,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- bioaihealth.com
- Keywords
- to dozens of clients worldwide..
- HQ
- Manchester, New Hampshire
Bioai Questions
Bioai's website is bioaihealth.com
Bioai's LinkedIn profile is https://www.linkedin.com/company/bio-ai-health
Bioai has
12 employees.
View email and phone details for 12
employees at Bioai.
Bioai's industry is
Biotechnology Research
Bioai's top competitors are
Pathai,
Bullfrog Ai,
Somite Ai,
Bio-Ai Lab,
Barts Cancer Institute (Queen Mary University Of London),
Amgen,
Bioai,
Genentech,
Arbele,
Bola Ai.
Bioai's categories are Biotechnology Research
Bioai's founding year is 2020
